» Authors » Frederic M Waldman

Frederic M Waldman

Explore the profile of Frederic M Waldman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 42
Citations 4156
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Suzuki J, Chen Y, Scott G, DeVries S, Chin K, Benz C, et al.
Clin Cancer Res . 2009 Apr; 15(9):3163-71. PMID: 19383825
Purpose: Excess histone deacetylase (HDAC) activity can induce hypoacetylation of histone and nonhistone protein substrates, altering gene expression patterns and cell behavior potentially associated with malignant transformation. However, HDAC expression...
12.
Nickerson M, Jaeger E, Shi Y, Durocher J, Mahurkar S, Zaridze D, et al.
Clin Cancer Res . 2008 Aug; 14(15):4726-34. PMID: 18676741
Purpose: To provide a comprehensive, thorough analysis of somatic mutation and promoter hypermethylation of the von Hippel-Lindau (VHL) gene in the cancer genome, unique to clear cell renal cancer (ccRCC)....
13.
Choueiri T, Vaziri S, Jaeger E, Elson P, Wood L, Bhalla I, et al.
J Urol . 2008 Jul; 180(3):860-5. PMID: 18635227
Purpose: The von Hippel-Lindau (VHL) gene is often inactivated (by mutation or promoter hypermethylation) in renal cell carcinoma but the relation to therapeutic outcome is unclear. Materials And Methods: Patients...
14.
Adduci K, Annis C, DeVries S, Chew K, Boutin J, Magrane G, et al.
Cancer . 2007 May; 111(3):185-91. PMID: 17474121
Background: Ductal lavage (DL) does not routinely identify cytologically malignant cells. For this study, the authors asked whether molecular analyses of DL specimens from women with cancer would identify abnormal...
15.
Korkola J, Blaveri E, DeVries S, Moore 2nd D, Hwang E, Chen Y, et al.
BMC Cancer . 2007 Apr; 7:61. PMID: 17428335
Background: Breast cancer is a heterogeneous disease, presenting with a wide range of histologic, clinical, and genetic features. Microarray technology has shown promise in predicting outcome in these patients. Methods:...
16.
Chin K, DeVries S, Fridlyand J, Spellman P, Roydasgupta R, Kuo W, et al.
Cancer Cell . 2006 Dec; 10(6):529-41. PMID: 17157792
This study explores the roles of genome copy number abnormalities (CNAs) in breast cancer pathophysiology by identifying associations between recurrent CNAs, gene expression, and clinical outcome in a set of...
17.
Neve R, Chin K, Fridlyand J, Yeh J, Baehner F, Fevr T, et al.
Cancer Cell . 2006 Dec; 10(6):515-27. PMID: 17157791
Recent studies suggest that thousands of genes may contribute to breast cancer pathophysiologies when deregulated by genomic or epigenomic events. Here, we describe a model "system" to appraise the functional...
18.
Sternlicht M, Dunning A, Moore D, Pharoah P, Ginzinger D, Chin K, et al.
Cancer Epidemiol Biomarkers Prev . 2006 Nov; 15(11):2107-14. PMID: 17119035
Plasminogen activator inhibitor-1 (PAI1) can promote cancer progression, and its protein expression in tumors is an independent indicator of poor prognosis in many forms of cancer. Here, we show that...
19.
Trautmann K, Terdiman J, French A, Roydasgupta R, Sein N, Kakar S, et al.
Clin Cancer Res . 2006 Nov; 12(21):6379-85. PMID: 17085649
Purpose: The genomic instability in colon cancer can be divided into at least two major types, microsatellite instability (MSI) or chromosomal instability (CIN). Although initially felt to be mutually exclusive,...
20.
Grossman H, Tangen C, Cordon-Cardo C, Cote R, Waldman F, de Vere White R, et al.
Oncol Rep . 2006 Sep; 16(4):807-10. PMID: 16969498
In this prospective biomarker study, we evaluated the prognostic significance of Ki67, p53 and angiogenesis in patients with locally advanced bladder cancer. The patients were volunteers from a Southwest Oncology...